The HAM Infliximab Study

Clinical trial NCT00823641 · TERMINATED

Trial details

NCT number: NCT00823641
Sponsor: Imperial College London
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

HTLV-I-associated Myelopathy

Start date: 2008-10-01
Primary completion: 2011-03-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.